Alastin Skincare Incโ€”a specialty aesthetics company dedicated to developing and marketing innovative, clinically-tested physician-dispensed skin care productsโ€”announces that the United States Patent and Trademark Office has issued US Patent No. 10,086,035 entitled โ€œCompositions and Methods for Invasive and Non-invasive Procedural Skin Care.”

The patent covers topical compositions for promoting skin repair based on Alastinโ€™s platform TriHex Technology.

Products with Alastinโ€™s TriHex Technology have created a new category within the aesthetic market to address a previously unmet need for topical products that provide complementary benefits for patients undergoing rejuvenating procedures. These products are designed to help patients prepare the skin prior to a procedure, speed healing, and enhance outcomes post-procedure.

Alastinโ€™s Procedure Enhancement Line of products supports the bodyโ€™s natural healing processes related to generation of new collagen and elastin after a procedure. This novel TriHex Technology is also incorporated into Alastinโ€™s Restore & Renew daily skin care line to improve skin health, helping the skin repair the wear and tear from normal aging and exposure to the sun and air pollution.

โ€œAccording to the 2017 report from the American Society of Plastic Surgeons, there were over 15 Million minimally invasive aesthetic procedures in the US, and this trend is growing rapidly,โ€ comments Diane S. Goostree, CEO of ALASTIN Skincare.

โ€œWe are pleased to provide patented products based on TriHex Technology to our physician partners and their patients to enhance these procedures, and for daily skin care.โ€

[Source: Kelz PR]